AllianceBernstein
NERV icon

AllianceBernstein’s Minerva Neurosciences NERV Stock Holding History

AllianceBernstein’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23,038
Closed -$538K – 3381
2021
Q1 		$538K Sell
23,038
-1,275
-5% -$31.9K ﹤0.01% 2631
2020
Q4 		$455K Sell
24,313
-1,712
-7% -$43.1K ﹤0.01% 2637
2020
Q3 		$662K Sell
26,025
-4,288
-14% -$116K ﹤0.01% 2387
2020
Q2 		$875K Buy
30,313
+19,800
+188% +$1.16M ﹤0.01% 2272
2020
Q1 		$506K Hold
10,513
– – ﹤0.01% 2346
2019
Q4 		$598K Hold
10,513
– – ﹤0.01% 2474
2019
Q3 		$652K Buy
10,513
+425
+4% +$24.1K ﹤0.01% 2431
2019
Q2 		$454K Buy
10,088
+4,125
+69% +$206K ﹤0.01% 2646
2019
Q1 		$375K Buy
5,963
+200
+3% +$12K ﹤0.01% 2654
2018
Q4 		$311K Hold
5,763
– – ﹤0.01% 2713
2018
Q3 		$579K Hold
5,763
– – ﹤0.01% 2565
2018
Q2 		$380K Buy
5,763
+263
+5% +$16K ﹤0.01% 2717
2018
Q1 		$275K Hold
5,500
– – ﹤0.01% 2727
2017
Q4 		$266K Buy
5,500
+300
+6% +$14.9K ﹤0.01% 2764
2017
Q3 		$316K Sell
5,200
-563
-10% -$32.3K ﹤0.01% 2747
2017
Q2 		$408K Sell
5,763
-1,262
-18% -$81.7K ﹤0.01% 2685
2017
Q1 		$455K Sell
7,025
-288
-4% -$22.4K ﹤0.01% 2573
2016
Q4 		$687K Hold
7,313
– – ﹤0.01% 2435
2016
Q3 		$826K Hold
7,313
– – ﹤0.01% 2316
2016
Q2 		$597K Buy
+7,313
New +$465K ﹤0.01% 2452

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein's NERV Position: Q2 2021 in Review

AllianceBernstein sold out of Minerva Neurosciences (NERV) in Q2 2021, closing a stake of 23,038 shares — an estimated $538K sold.

AllianceBernstein first reported a position in NERV in Q2 2016 and held it in 20 quarters. The position peaked at $875K in Q2 2020. 68 funds tracked by Wall St. Rank hold NERV as of Q2 2021.

  • AllianceBernstein reported no remaining Minerva Neurosciences position as of Q2 2021 after selling out during the quarter.
  • AllianceBernstein sold 23,038 Minerva Neurosciences shares in Q2 2021, an estimated $538K.
  • AllianceBernstein first reported a position in Minerva Neurosciences in Q2 2016 and held it in 20 quarters.
  • AllianceBernstein's Minerva Neurosciences position peaked at $875K in Q2 2020.
  • 68 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2021.

Based on AllianceBernstein's 13F filing for Q2 2021, filed 30 Jul 2021.